atopic dermatitis

An arrow incrementally going up stairs before pointing straight up Blue background
Biotech

Leo's eczema prospect hits primary endpoint in phase 2b

Leo shared phase 2b data on temtokibart, reporting that the top three doses of the IL-22RA1 blocker beat placebo on the primary endpoint.
Nick Paul Taylor May 9, 2025 7:30am
rocket launch satellite space fly blast off

Amgen ignites Rocket program with wins in phase 3 eczema trials

Mar 10, 2025 5:48am
team layoffs workforce

Q32 Bio sticks with bempikibart but lets go of staff

Feb 11, 2025 4:47am
MA

Ikena, after tough year of layoffs, merges with Inmagene

Dec 23, 2024 10:00am
Person throwing piece of paper into full waste bin

Anaptys scraps atopic dermatitis asset after ph. 2 fail

Dec 11, 2024 11:02am
eczema atopic dermatitis Black African American patient skin of color

Q32's stock plunges in wake of anti-IL-7R antibody's eczema fail

Dec 11, 2024 8:25am